Becton Dickinson revenue
Becton Dickinson's revenue was $21.84bn in fiscal 2025, up 8.2% on the year before. Since fiscal 2009 ($6.99bn) it has grown at a compound 7.4% a year. Over the last twelve months it was $23.25bn.
Revenue history
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.0 | 7.1 | 7.6 | 7.7 | 8.1 | 8.4 | 10.3 | 12.5 | 12.1 | 16.0 | 17.3 | 16.1 | 19.1 | 18.9 | 19.4 | 20.2 | 21.8 | 23.3 |
| Growth on the year before | — | +2.0% | +6.5% | +1.6% | +4.5% | +4.9% | +21.7% | +21.4% | −3.1% | +32.2% | +8.2% | −7.0% | +19.0% | −1.4% | +2.7% | +4.2% | +8.2% | — |
| Gross profit | 3.7 | 3.7 | 4.0 | 4.0 | 4.2 | 4.3 | 4.7 | 6.0 | 5.9 | 7.3 | 8.3 | 7.6 | 8.6 | 8.5 | 8.2 | 9.1 | 9.9 | 10.9 |
| Gross margin | 52.6% | 51.9% | 52.2% | 51.3% | 51.8% | 50.9% | 45.7% | 48.0% | 49.1% | 45.5% | 47.9% | 47.1% | 45.1% | 44.9% | 42.2% | 45.2% | 45.4% | 46.9% |
Where the revenue comes from
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $12.8B | 58.6% | ▲ 9.7% |
| Outside the US | $9B | 41.4% | ▲ 6.3% |
| EMEA (part of Outside the US) | $4.7B | 52.3% | ▲ 7.4% |
| Asia (part of Outside the US) | $3.1B | 34.2% | ▲ 6.4% |
| Others Country (part of Outside the US) | $1.2B | 13.6% | ▲ 1.7% |
From Becton Dickinson's 10-K filed November 25, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Becton Dickinson | $23.25bn | 17.4% | 6.9% |
| GE HealthCare | $21.64bn | 6.9% | 3.9% |
| Boston Scientific | $21.07bn | 8.9% | 15.3% |
| Stryker Corporation | $26.30bn | 7.9% | 9.8% |
| Koninklijke Philips NV | $20.16bn | 3.4% | — |
| Medtronic | $37.54bn | 9.8% | 6.0% |
Compare with peers
- GE HealthCare revenue
- Boston Scientific revenue
- Stryker Corporation revenue
- Koninklijke Philips NV revenue
- Medtronic revenue
Head to head: BDX vs GEHCBDX vs BSXBDX vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies